{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:39Z","timestamp":1792785039690,"version":"4.5.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Digital Society Initiative, UZH"},{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","award":["333\/20"],"award-info":[{"award-number":["333\/20"]}],"id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","award":["333\/20"],"award-info":[{"award-number":["333\/20"]}],"id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reconnect Foundation"},{"name":"European Varela Award from Mind and Life Europe","award":["# 2021EVA-Scheidegger, Milan"],"award-info":[{"award-number":["# 2021EVA-Scheidegger, Milan"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The acute subjective effects (ASEs) of psychedelic substances are assumed to play a critical role for their therapeutic and well-being enhancing benefits. However, recent work voiced critique regarding the validity and adequacy of conventional measures and modalities utilized to study ASEs of psychedelics, and call for data-driven, unbiased, and experience-based research approaches. The emergence of advanced Natural Language Processing techniques as an enabler of data-driven qualitative research holds promise for addressing the current biases and limitations in the investigation of ASEs of psychedelics. In the present study, we employed an NLP-driven, multi-method analytical paradigm to study the subjective experiences of participants in an ecologically valid RCT examining the effect of DMT\/harmine on meditative states in experienced meditators using phenomenological interviews. Our analysis showed differences in the thematic landscape and experiential diversity of meditation under placebo and meditation under DMT-harmine while showing overlap in their semantic topographies. The mixed-modal analysis successfully identified a wide range of well-established primary subjective effects while also detecting subtle, patterned regularities in language that traditional hypothesis-driven approaches alone may overlook. It revealed a pronounced use of Buddhist concepts and spiritual jargon to describe and integrate the subjective experience, independent of the experimental condition. Findings suggested shared experiential features between meditative and psychedelic states, a strong drug-context interconnection and potential synergistic effects of meditation and psychedelics. We advocate for using NLP-augmented, data-driven paradigms to deepen the understanding of psychedelic subjectivity and emphasize the importance of extra-pharmacological factors in shaping therapeutic outcomes.<\/jats:p>","DOI":"10.1038\/s41598-026-39261-5","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:33:30Z","timestamp":1773837210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat"],"prefix":"10.1038","volume":"16","author":[{"given":"Jonas T. T.","family":"Schlomberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Meling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Grylka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia A.","family":"Vasella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Augustinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Scheidegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"39261_CR1","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00213-024-06599-5","volume":"242","author":"MA Atiq","year":"2025","unstructured":"Atiq, M. A., Baker, M. R., Voort, J. L. V., Vargas, M. V. & Choi, D. S. Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties. Psychopharmacology 242, 1481\u20131506 (2025).","journal-title":"Psychopharmacology"},{"key":"39261_CR2","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/02698811231180276","volume":"37","author":"OR Hovmand","year":"2023","unstructured":"Hovmand, O. R., Poulsen, E. D., Arnfred, S. & Storeb\u00f8, O. J. Risk of bias in randomized clinical trials on psychedelic medicine: a systematic review. J. Psychopharmacol. 37, 649\u2013659 (2023).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR3","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","volume":"4","author":"DB Yaden","year":"2021","unstructured":"Yaden, D. B. & Griffiths, R. R. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacol. Transl Sci. 4, 568\u2013572 (2021).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"39261_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s44159-024-00345-6","volume":"3","author":"DB Yaden","year":"2024","unstructured":"Yaden, D. B., Goldy, S. P., Weiss, B. & Griffiths, R. R. Clinically relevant acute subjective effects of psychedelics beyond mystical experience. Nat. Rev. Psychol. 3, 606\u2013621 (2024).","journal-title":"Nat. Rev. Psychol."},{"key":"39261_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.13249","volume":"143","author":"KAA Andersen","year":"2021","unstructured":"Andersen, K. A. A., Carhart-Harris, R., Nutt, D. J. & Erritzoe, D. Therapeutic effects of classic serotonergic psychedelics: a systematic review of modern\u2010era clinical studies. Acta Psychiatr Scand. 143, 101\u2013118 (2021).","journal-title":"Acta Psychiatr Scand."},{"key":"39261_CR6","doi-asserted-by":"crossref","unstructured":"Ko, K., Knight, G., Rucker, J. J., Cleare, A. J. & Psychedelics Mystical Experience, and therapeutic efficacy: a systematic review. Front. Psychiatry. 13, 917199 (2022).","DOI":"10.3389\/fpsyt.2022.917199"},{"key":"39261_CR7","doi-asserted-by":"publisher","first-page":"1386321","DOI":"10.3389\/fpsyt.2024.1386321","volume":"15","author":"Z Yu","year":"2024","unstructured":"Yu, Z. et al. Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review. Front. Psychiatry. 15, 1386321 (2024).","journal-title":"Front. Psychiatry"},{"key":"39261_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","volume":"4","author":"DE Olson","year":"2021","unstructured":"Olson, D. E. The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects. ACS Pharmacol. Transl Sci. 4, 563\u2013567 (2021).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"39261_CR9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3389\/fpsyg.2018.01475","volume":"9","author":"R Milli\u00e8re","year":"2018","unstructured":"Milli\u00e8re, R. et al. Meditation, and Self-Consciousness. Front. Psychol. 9, 1475 (2018).","journal-title":"Front. Psychol."},{"key":"39261_CR10","unstructured":"Scheidegger, M. Comparative phenomenology and neurobiology of meditative and psychedelic States of consciousness: implications for psychedelic\u2013assisted therapy. In Handbook of Medical Hallucinogens 395\u2013413 (The Guilford Press, 2021)."},{"key":"39261_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s12671-023-02103-w","volume":"14","author":"C Simonsson","year":"2023","unstructured":"Simonsson, C. et al. Classic psychedelic use and current meditation practice. Mindfulness 14, 763\u2013768 (2023).","journal-title":"Mindfulness"},{"key":"39261_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cpr.2017.10.011","volume":"59","author":"SB Goldberg","year":"2018","unstructured":"Goldberg, S. B. et al. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin. Psychol. Rev. 59, 52\u201360 (2018).","journal-title":"Clin. Psychol. Rev."},{"key":"39261_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12671-019-01277-6","volume":"11","author":"S Rose","year":"2020","unstructured":"Rose, S., Zell, E. & Strickhouser, J. E. The effect of meditation on health: a metasynthesis of randomized controlled trials. Mindfulness 11, 507\u2013516 (2020).","journal-title":"Mindfulness"},{"key":"39261_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0269881117731279","volume":"32","author":"RR Griffiths","year":"2018","unstructured":"Griffiths, R. R. et al. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J. Psychopharmacol. 32, 49\u201369 (2018).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR15","doi-asserted-by":"publisher","first-page":"14914","DOI":"10.1038\/s41598-019-50612-3","volume":"9","author":"L Smigielski","year":"2019","unstructured":"Smigielski, L. et al. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat. Sci. Rep. 9, 14914 (2019).","journal-title":"Sci. Rep."},{"key":"39261_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF01532646","volume":"5","author":"WN Pahnke","year":"1966","unstructured":"Pahnke, W. N. & Richards, W. A. Implications of LSD and experimental mysticism. J. Relig. Health. 5, 175\u2013208 (1966).","journal-title":"J. Relig. Health"},{"key":"39261_CR17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1177\/0269881115609019","volume":"29","author":"FS Barrett","year":"2015","unstructured":"Barrett, F. S., Johnson, M. W. & Griffiths, R. R. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. J. Psychopharmacol. 29, 1182\u20131190 (2015).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR18","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2007-979351","volume":"31","author":"A Dittrich","year":"1998","unstructured":"Dittrich, A. The standardized psychometric assessment of altered States of consciousness (ASCs) in humans. Pharmacopsychiatry 31, 80\u201384 (1998).","journal-title":"Pharmacopsychiatry"},{"key":"39261_CR19","doi-asserted-by":"publisher","unstructured":"Bzdok, D., Carhart-Harris, R., Savignac, C., Bell, G. & Laureys, S. Large Language models auto-profile conscious awareness changes under psychedelic drug effects. Preprint at. https:\/\/doi.org\/10.21203\/rs.3.rs-4670805\/v1 (2024).","DOI":"10.21203\/rs.3.rs-4670805\/v1"},{"key":"39261_CR20","doi-asserted-by":"crossref","unstructured":"Bouso, J. C., Pedrero-P\u00e9rez, E. J., Gandy, S. & Alc\u00e1zar-C\u00f3rcoles, M. \u00c1. Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens. Hum. Psychopharmacol.: Clin. Exp. 31, 256 (2016).","DOI":"10.1002\/hup.2545"},{"key":"39261_CR21","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.3390\/ijerph16245147","volume":"16","author":"H Kettner","year":"2019","unstructured":"Kettner, H., Gandy, S., Haijen, E. C. H. M. & Carhart-Harris, R. L. From egoism to ecoism: psychedelics increase nature relatedness in a State-Mediated and Context-Dependent manner. IJERPH 16, 5147 (2019).","journal-title":"IJERPH"},{"key":"39261_CR22","doi-asserted-by":"publisher","first-page":"15998","DOI":"10.1038\/s41598-023-41145-x","volume":"13","author":"R Bremler","year":"2023","unstructured":"Bremler, R., Katati, N., Shergill, P., Erritzoe, D. & Carhart-Harris, R. L. Case analysis of long-term negative psychological responses to psychedelics. Sci. Rep. 13, 15998 (2023).","journal-title":"Sci. Rep."},{"key":"39261_CR23","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1021\/acsptsci.1c00097","volume":"4","author":"JW Sanders","year":"2021","unstructured":"Sanders, J. W. & Zijlmans, J. Moving past mysticism in psychedelic science. ACS Pharmacol. Transl Sci. 4, 1253\u20131255 (2021).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"39261_CR24","doi-asserted-by":"publisher","first-page":"1077311","DOI":"10.3389\/fpsyt.2023.1077311","volume":"14","author":"S Mosurinjohn","year":"2023","unstructured":"Mosurinjohn, S., Roseman, L. & Girn, M. Psychedelic-induced mystical experiences: an interdisciplinary discussion and critique. Front. Psychiatry. 14, 1077311 (2023).","journal-title":"Front. Psychiatry"},{"key":"39261_CR25","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1038\/s41386-023-01607-2","volume":"48","author":"L Ley","year":"2023","unstructured":"Ley, L. et al. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants. Neuropsychopharmacol 48, 1659\u20131667 (2023).","journal-title":"Neuropsychopharmacol"},{"key":"39261_CR26","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","volume":"47","author":"F Holze","year":"2022","unstructured":"Holze, F. et al. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects. Neuropsychopharmacol 47, 1180\u20131187 (2022).","journal-title":"Neuropsychopharmacol"},{"key":"39261_CR27","doi-asserted-by":"publisher","first-page":"1397064","DOI":"10.3389\/fpsyg.2024.1397064","volume":"15","author":"S Noah","year":"2024","unstructured":"Noah, S., Shen, M., Erowid, E., Erowid, F. & Silver, M. A novel method for quantitative analysis of subjective experience reports: application to psychedelic visual experiences. Front. Psychol. 15, 1397064 (2024).","journal-title":"Front. Psychol."},{"key":"39261_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fnint.2018.00054","volume":"12","author":"F Zamberlan","year":"2018","unstructured":"Zamberlan, F. et al. The varieties of the psychedelic experience: a preliminary study of the association between the reported subjective effects and the binding affinity profiles of substituted phenethylamines and tryptamines. Front. Integr. Neurosci. 12, 54 (2018).","journal-title":"Front. Integr. Neurosci."},{"key":"39261_CR29","doi-asserted-by":"publisher","unstructured":"Agnorelli, C. et al. Neuroplasticity and psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models. Preprint at. https:\/\/doi.org\/10.48550\/ARXIV.2411.19840 (2024).","DOI":"10.48550\/ARXIV.2411.19840"},{"key":"39261_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02791072.2021.2022254","volume":"55","author":"A Hadar","year":"2023","unstructured":"Hadar, A. et al. The psychedelic renaissance in clinical research: a bibliometric analysis of three decades of human studies with psychedelics. J. Psychoactive Drugs. 55, 1\u201310 (2023).","journal-title":"J. Psychoactive Drugs"},{"key":"39261_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/02791072.2021.1874573","volume":"53","author":"DW Lawrence","year":"2021","unstructured":"Lawrence, D. W., Sharma, B., Griffiths, R. R. & Carhart-Harris, R. Trends in the top-cited articles on classic psychedelics. J. Psychoactive Drugs. 53, 283\u2013298 (2021).","journal-title":"J. Psychoactive Drugs"},{"key":"39261_CR32","doi-asserted-by":"crossref","unstructured":"Carhart-Harris, R. L. et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc. Natl. Acad. Sci. U.S.A. 109, 2138\u20132143 (2012).","DOI":"10.1073\/pnas.1119598109"},{"key":"39261_CR33","doi-asserted-by":"crossref","unstructured":"Carhart-Harris, R. L. et al. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc. Natl. Acad. Sci. U.S.A. 113, 4853\u20134858 (2016).","DOI":"10.1073\/pnas.1518377113"},{"key":"39261_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00018-024-05353-6","volume":"81","author":"K Egger","year":"2024","unstructured":"Egger, K., Aicher, H. D., Cumming, P. & Scheidegger, M. Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from Ayahuasca to synthetic combinations of DMT and MAO inhibitors. Cell. Mol. Life Sci. 81, 395 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"39261_CR35","doi-asserted-by":"publisher","first-page":"247054702211153","DOI":"10.1177\/24705470221115342","volume":"6","author":"S Kuburi","year":"2022","unstructured":"Kuburi, S. et al. Neuroimaging correlates of treatment response with psychedelics in major depressive disorder: a systematic review. Chronic Stress. 6, 24705470221115342 (2022).","journal-title":"Chronic Stress"},{"key":"39261_CR36","doi-asserted-by":"crossref","unstructured":"Locher, C., Meier, S., Gaab, J. & Psychotherapy A world of meanings. Front. Psychol. 10, 2563 (2019).","DOI":"10.3389\/fpsyg.2019.00460"},{"key":"39261_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/anoc.12170","volume":"34","author":"OJ Graham","year":"2022","unstructured":"Graham, O. J., Saucedo, G. R. & Politi, M. Experiences of listening to Icaros during Ayahuasca ceremonies at Centro takiwasi:an interpretive phenomenological analysis. Anthropol. Conscious. 34, 35\u201367 (2022).","journal-title":"Anthropol. Conscious."},{"key":"39261_CR38","doi-asserted-by":"publisher","unstructured":"Costines, C. & Schmidt, T. T. Phenomenology of Psychedelic Experiences and Psychedelic-Associated Distressing Effects: Quantifying Subjective Experiences (Springer Berlin Heidelberg, 2024). https:\/\/doi.org\/10.1007\/7854_2024_562.","DOI":"10.1007\/7854_2024_562"},{"key":"39261_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.tics.2022.11.006","volume":"27","author":"C Timmermann","year":"2023","unstructured":"Timmermann, C. et al. A neurophenomenological approach to non-ordinary States of consciousness: hypnosis, meditation, and psychedelics. Trends Cogn. Sci. 27, 139\u2013159 (2023).","journal-title":"Trends Cogn. Sci."},{"key":"39261_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpsc.2024.11.008","author":"A Lutz","year":"2024","unstructured":"Lutz, A., Abdoun, O., Dor-Ziderman, Y., Trautwein, F. M. & Berkovich-Ohana, A. An overview of neurophenomenological approaches to meditation and their relevance to clinical research. Biol. Psychiatry: Cogn. Neurosci. Neuroimaging. https:\/\/doi.org\/10.1016\/j.bpsc.2024.11.008 (2024).","journal-title":"Biol. Psychiatry: Cogn. Neurosci. Neuroimaging"},{"key":"39261_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s43856-024-00546-3","volume":"4","author":"C Haag","year":"2024","unstructured":"Haag, C. et al. Natural Language processing analysis of the theories of people with multiple sclerosis about causes of their disease. Commun. Med. 4, 122 (2024).","journal-title":"Commun. Med."},{"key":"39261_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.54254\/2755-2721\/97\/20241406","volume":"97","author":"M Ren","year":"2024","unstructured":"Ren, M. Advancements and applications of large Language models in natural Language processing: a comprehensive review. ACE 97, 55\u201363 (2024).","journal-title":"ACE"},{"key":"39261_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/jamia.2009.001560","volume":"17","author":"GK Savova","year":"2010","unstructured":"Savova, G. K. et al. Mayo clinical text analysis and knowledge extraction system (cTAKES): architecture, component evaluation and applications. J. Am. Med. Inf. Assoc. 17, 507\u2013513 (2010).","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"39261_CR44","doi-asserted-by":"publisher","unstructured":"Vaswani, A. et al. Attention is all you need (2017). https:\/\/doi.org\/10.48550\/ARXIV.1706.03762.","DOI":"10.48550\/ARXIV.1706.03762"},{"key":"39261_CR45","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2025.00441","author":"D Dikovskaya","year":"2025","unstructured":"Dikovskaya, D. et al. Natural Language analysis of the structure of altered States of consciousness. JPS https:\/\/doi.org\/10.1556\/2054.2025.00441 (2025). doi:10.1556\/2054.2025.00441.","journal-title":"JPS"},{"key":"39261_CR46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00213-022-06062-3","volume":"239","author":"A Hase","year":"2022","unstructured":"Hase, A., Erdmann, M., Limbach, V. & Hasler, G. Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology 239, 643\u2013659 (2022).","journal-title":"Psychopharmacology"},{"key":"39261_CR47","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.concog.2020.103070","volume":"87","author":"C Sanz","year":"2021","unstructured":"Sanz, C. et al. The entropic tongue: disorganization of natural Language under LSD. Conscious. Cogn. 87, 103070 (2021).","journal-title":"Conscious. Cogn."},{"key":"39261_CR48","unstructured":"Erowid Erowid Experience Vaults (2025)."},{"key":"39261_CR49","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1177\/02698811241282637","volume":"38","author":"D Meling","year":"2024","unstructured":"Meling, D. et al. Meditating on psychedelics. A randomized placebo-controlled study of DMT and Harmine in a mindfulness retreat. J. Psychopharmacol. 38, 897\u2013910 (2024).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR50","doi-asserted-by":"publisher","first-page":"117908","DOI":"10.1016\/j.biopha.2025.117908","volume":"184","author":"K Egger","year":"2025","unstructured":"Egger, K. et al. Examining the Pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and Harmine in healthy volunteers: a factorial dose-escalation study. Biomed. Pharmacother. 184, 117908 (2025).","journal-title":"Biomed. Pharmacother."},{"key":"39261_CR51","first-page":"269","volume":"8","author":"M Bitbol","year":"2013","unstructured":"Bitbol, M. & Petitmengin, C. A defense of introspection from within. Constructivist Found. 8, 269\u2013279 (2013).","journal-title":"Constructivist Found."},{"key":"39261_CR52","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11097-018-9597-4","volume":"18","author":"C Petitmengin","year":"2019","unstructured":"Petitmengin, C., Remillieux, A. & Valenzuela-Moguillansky, C. Discovering the structures of lived experience: towards a micro-phenomenological analysis method. Phenom. Cogn. Sci. 18, 691\u2013730 (2019).","journal-title":"Phenom. Cogn. Sci."},{"key":"39261_CR53","doi-asserted-by":"crossref","unstructured":"Petitmengin, C. & Lachaux, J. P. Microcognitive science: bridging experiential and neuronal microdynamics. Front. Hum. Neurosci. 7, 859 (2013).","DOI":"10.3389\/fnhum.2013.00617"},{"key":"39261_CR54","unstructured":"Dr\u00f6ge, K. noScribe. AI-powered Audio Transcription (2024)."},{"key":"39261_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s42466-020-00059-z","volume":"2","author":"L Busetto","year":"2020","unstructured":"Busetto, L., Wick, W. & Gumbinger, C. How to use and assess qualitative research methods. Neurol. Res. Pract. 2, 14 (2020).","journal-title":"Neurol. Res. Pract."},{"key":"39261_CR56","unstructured":"spaCy. German - Available trained pipelines for German. spaCy (2025). https:\/\/spacy.io\/models\/de."},{"key":"39261_CR57","unstructured":"Software, V. E. R. B. I. MAXQDA 2024. VERBI Software (2023)."},{"key":"39261_CR58","doi-asserted-by":"publisher","unstructured":"Grootendorst, M. & BERTopic Neural topic modeling with a class-based TF-IDF procedure (2022). https:\/\/doi.org\/10.48550\/ARXIV.2203.05794.","DOI":"10.48550\/ARXIV.2203.05794"},{"key":"39261_CR59","doi-asserted-by":"crossref","unstructured":"Reimers, N. & Gurevych, I. Sentence-BERT sentence embeddings using Siamese BERT-networks. In Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing (Association for Computational Linguistics, 2019).","DOI":"10.18653\/v1\/D19-1410"},{"key":"39261_CR60","doi-asserted-by":"publisher","unstructured":"Montemurro, M. A. & Zanette, D. Towards the quantification of the semantic information encoded in written language (2009). https:\/\/doi.org\/10.48550\/ARXIV.0907.1558.","DOI":"10.48550\/ARXIV.0907.1558"},{"key":"39261_CR61","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1073\/pnas.1012551108","volume":"108","author":"ST Piantadosi","year":"2011","unstructured":"Piantadosi, S. T., Tily, H. & Gibson, E. Word lengths are optimized for efficient communication. Proc. Natl. Acad. Sci. U S A. 108, 3526\u20133529 (2011).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"39261_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1145\/1273340.1273347","volume":"3","author":"P Indyk","year":"2007","unstructured":"Indyk, P. & Naor, A. Nearest-neighbor-preserving embeddings. ACM Trans. Algorithms. 3, 31\u2013es (2007).","journal-title":"ACM Trans. Algorithms"},{"key":"39261_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cag.2014.01.006","volume":"41","author":"RM Martins","year":"2014","unstructured":"Martins, R. M., Coimbra, D. B., Minghim, R. & Telea, A. C. Visual analysis of dimensionality reduction quality for parameterized projections. Comput.Graph. 41, 26\u201342 (2014).","journal-title":"Comput.Graph."},{"key":"39261_CR64","doi-asserted-by":"publisher","unstructured":"McInnes, L., Healy, J. & Melville, J. U. M. A. P. Uniform Manifold approximation and projection for dimension reduction (2018). https:\/\/doi.org\/10.48550\/ARXIV.1802.03426.","DOI":"10.48550\/ARXIV.1802.03426"},{"key":"39261_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.21105\/joss.00205","volume":"2","author":"L McInnes","year":"2017","unstructured":"McInnes, L., Healy, J. & Astels, S. Hdbscan: hierarchical density based clustering. JOSS 2, 205 (2017).","journal-title":"JOSS"},{"key":"39261_CR66","doi-asserted-by":"publisher","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in python (2012). https:\/\/doi.org\/10.48550\/ARXIV.1201.0490.","DOI":"10.48550\/ARXIV.1201.0490"},{"key":"39261_CR67","unstructured":"Jurafsky, D. & Martin, J. H. Speech and Language Processing (Pearson, 2014)."},{"key":"39261_CR68","doi-asserted-by":"publisher","unstructured":"Qi, P., Zhang, Y., Zhang, Y., Bolton, J. & Manning, C. D. Stanza: a python natural language processing toolkit for many human languages (2020). https:\/\/doi.org\/10.48550\/ARXIV.2003.07082.","DOI":"10.48550\/ARXIV.2003.07082"},{"key":"39261_CR69","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1145\/3130348.3130369","volume":"51","author":"J Carbonell","year":"2017","unstructured":"Carbonell, J. & Goldstein, J. The use of MMR, Diversity-Based reranking for reordering documents and producing summaries. SIGIR Forum. 51, 209\u2013210 (2017).","journal-title":"SIGIR Forum"},{"key":"39261_CR70","doi-asserted-by":"publisher","first-page":"1271385","DOI":"10.3389\/frma.2023.1271385","volume":"8","author":"O Lezhnina","year":"2023","unstructured":"Lezhnina, O. Depression, anxiety, and burnout in academia: topic modeling of pubmed abstracts. Front. Res. Metr. Anal. 8, 1271385 (2023).","journal-title":"Front. Res. Metr. Anal."},{"key":"39261_CR71","doi-asserted-by":"publisher","unstructured":"DeepSeek-AI et al. DeepSeek-R1: incentivizing reasoning capability in LLMs via reinforcement learning (2025). https:\/\/doi.org\/10.48550\/ARXIV.2501.12948.","DOI":"10.48550\/ARXIV.2501.12948"},{"key":"39261_CR72","unstructured":"Mueller, A. WordCoud A little word cloud generator in python (2024). https:\/\/github.com\/amueller\/word_cloud."},{"key":"39261_CR73","doi-asserted-by":"publisher","unstructured":"Baeza-Yates, R. & Liaghat, Z. Quality-efficiency trade-offs in machine learning for text processing (2017). https:\/\/doi.org\/10.48550\/ARXIV.1711.02295.","DOI":"10.48550\/ARXIV.1711.02295"},{"key":"39261_CR74","doi-asserted-by":"publisher","unstructured":"ter Hoeve, M., Grangier, D. & Schluter, N. High-resource methodological bias in low-resource investigations (2022). https:\/\/doi.org\/10.48550\/ARXIV.2211.07534.","DOI":"10.48550\/ARXIV.2211.07534"},{"key":"39261_CR75","doi-asserted-by":"crossref","unstructured":"Nguyen, D. & Ploeger, E. We Need to Measure Data Diversity in NLP - Better and Broader (2025).","DOI":"10.18653\/v1\/2025.emnlp-main.445"},{"key":"39261_CR76","unstructured":"Breuer, F. Subjectivity and reflexivity in the social sciences: epistemic windows and methodical consequences. In Forum Qualitative Sozialforschung \/ Forum: Qualitative Social Research. Subjectivity and Reflexivity in Qualitative Research II, vol. 4 2 (2003)."},{"key":"39261_CR77","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF00988842","volume":"8","author":"S Krieger","year":"1985","unstructured":"Krieger, S. Beyond \u2018subjectivity\u2019: the use of the self in social science. Qual. Sociol. 8, 309\u2013324 (1985).","journal-title":"Qual. Sociol."},{"key":"39261_CR78","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1021\/acsptsci.1c00034","volume":"4","author":"JE Payne","year":"2021","unstructured":"Payne, J. E., Chambers, R. & Liknaitzky, P. Combining psychedelic and mindfulness interventions: synergies to inform clinical practice. ACS Pharmacol. Transl Sci. 4, 416\u2013423 (2021).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"39261_CR79","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/02791072.2021.2022816","volume":"55","author":"O Simonsson","year":"2023","unstructured":"Simonsson, O. & Goldberg, S. B. Linkages between psychedelics and meditation in a Population-Based sample in the united States. J. Psychoactive Drugs. 55, 11\u201318 (2023).","journal-title":"J. Psychoactive Drugs"},{"key":"39261_CR80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.euroneuro.2022.12.013","volume":"68","author":"I Wie\u00dfner","year":"2023","unstructured":"Wie\u00dfner, I. et al. LSD and language: decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals. Eur. Neuropsychopharmacol. 68, 89\u2013104 (2023).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"39261_CR81","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0022167817709585","volume":"57","author":"R Watts","year":"2017","unstructured":"Watts, R., Day, C., Krzanowski, J., Nutt, D. & Carhart-Harris, R. Patients\u2019 accounts of increased connectedness and acceptance after psilocybin for Treatment-Resistant depression. J. Humanistic Psychol. 57, 520\u2013564 (2017).","journal-title":"J. Humanistic Psychol."},{"key":"39261_CR82","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths, R. R., Richards, W. A., McCann, U. & Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187, 268\u2013283 (2006).","journal-title":"Psychopharmacology"},{"key":"39261_CR83","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0269881108094300","volume":"22","author":"R Griffiths","year":"2008","unstructured":"Griffiths, R., Richards, W., Johnson, M., McCann, U. & Jesse, R. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J. Psychopharmacol. 22, 621\u2013632 (2008).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR84","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-017-4701-y","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M. & Watts, R. Psychedelics and connectedness. Psychopharmacology 235, 547\u2013550 (2018).","journal-title":"Psychopharmacology"},{"key":"39261_CR85","unstructured":"Richards, W. A. & Barnard, G. W. Sacred Knowledge: Psychedelics and Religious Experiences (Columbia University, 2018)."},{"key":"39261_CR86","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/13634615211036388","volume":"59","author":"D Dupuis","year":"2022","unstructured":"Dupuis, D. The socialization of hallucinations: cultural priors, social interactions, and contextual factors in the use of psychedelics. Transcult Psychiatry. 59, 625\u2013637 (2022).","journal-title":"Transcult Psychiatry"},{"key":"39261_CR87","doi-asserted-by":"publisher","first-page":"e0214377","DOI":"10.1371\/journal.pone.0214377","volume":"14","author":"RR Griffiths","year":"2019","unstructured":"Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W. & Jesse, R. Survey of subjective \u2018God encounter experiences\u2019: comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLoS ONE. 14, e0214377 (2019).","journal-title":"PLoS ONE"},{"key":"39261_CR88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1037\/rel0000561","volume":"17","author":"AD Cherniak","year":"2025","unstructured":"Cherniak, A. D. & Granqvist, P. How does psychedelic use relate to aspects of religiosity\/spirituality? Preregistered report from a birth cohort study and a prospective longitudinal study. Psychol. Relig. Spiritual. 17, 175\u2013194 (2025).","journal-title":"Psychol. Relig. Spiritual."},{"key":"39261_CR89","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/02698811241249698","volume":"38","author":"M Wolff","year":"2024","unstructured":"Wolff, M. et al. Measuring psychotherapeutic processes in the context of psychedelic experiences: validation of the general change mechanisms questionnaire (GCMQ). J. Psychopharmacol. 38, 432\u2013457 (2024).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR90","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s40263-023-01053-0","volume":"37","author":"KT Greenway","year":"2023","unstructured":"Greenway, K. T. Context is a critical for psychoactive drug effects. CNS Drugs. 37, 1065\u20131068 (2023).","journal-title":"CNS Drugs"},{"key":"39261_CR91","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/0269881116677852","volume":"30","author":"I Hartogsohn","year":"2016","unstructured":"Hartogsohn, I. Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology. J. Psychopharmacol. 30, 1259\u20131267 (2016).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR92","doi-asserted-by":"publisher","first-page":"205032451668332","DOI":"10.1177\/2050324516683325","volume":"3","author":"I Hartogsohn","year":"2017","unstructured":"Hartogsohn, I. Constructing drug effects: a history of set and setting. Drug Sci. Policy Law. 3, 2050324516683325 (2017).","journal-title":"Drug Sci. Policy Law"},{"key":"39261_CR93","doi-asserted-by":"publisher","unstructured":"Adamczyk, S. et al. Setting the stage for the inner journey: unraveling the interplay of contextual factors and the intensity of ego-dissolution in naturalistic psychedelic experiences. https:\/\/doi.org\/10.31219\/osf.io\/qpx2z_v3 (2025).","DOI":"10.31219\/osf.io\/qpx2z_v3"},{"key":"39261_CR94","doi-asserted-by":"publisher","first-page":"111361","DOI":"10.1016\/j.pnpbp.2025.111361","volume":"138","author":"CJ Healy","year":"2025","unstructured":"Healy, C. J. et al. Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories. Prog. Neuropsychopharmacol. Biol. Psychiatry. 138, 111361 (2025).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"39261_CR95","doi-asserted-by":"publisher","first-page":"1100058","DOI":"10.3389\/fpsyg.2023.1100058","volume":"14","author":"D Meling","year":"2023","unstructured":"Meling, D. & Scheidegger, M. Not in the drug, not in the brain: causality in psychedelic experiences from an enactive perspective. Front. Psychol. 14, 1100058 (2023).","journal-title":"Front. Psychol."},{"key":"39261_CR96","doi-asserted-by":"publisher","first-page":"e0293349","DOI":"10.1371\/journal.pone.0293349","volume":"18","author":"J Evans","year":"2023","unstructured":"Evans, J. et al. Extended difficulties following the use of psychedelic drugs: a mixed methods study. PLoS ONE. 18, e0293349 (2023).","journal-title":"PLoS ONE"},{"key":"39261_CR97","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12954-022-00662-0","volume":"19","author":"M Palmer","year":"2022","unstructured":"Palmer, M. & Maynard, O. M. Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience. Harm Reduct. J. 19, 81 (2022).","journal-title":"Harm Reduct. J."},{"key":"39261_CR98","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1177\/02698811221084063","volume":"36","author":"EI Kopra","year":"2022","unstructured":"Kopra, E. I., Ferris, J. A., Winstock, A. R., Young, A. H. & Rucker, J. J. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. J. Psychopharmacol. 36, 965\u2013973 (2022).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR99","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/02698811211069100","volume":"36","author":"AK Schlag","year":"2022","unstructured":"Schlag, A. K., Aday, J., Salam, I., Neill, J. C. & Nutt, D. J. Adverse effects of psychedelics: from anecdotes and misinformation to systematic science. J. Psychopharmacol. 36, 258\u2013272 (2022).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR100","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0269881119855974","volume":"33","author":"L Roseman","year":"2019","unstructured":"Roseman, L. et al. Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory. J. Psychopharmacol. 33, 1076\u20131087 (2019).","journal-title":"J. Psychopharmacol."},{"key":"39261_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03685-9","author":"C Pronovost-Morgan","year":"2025","unstructured":"Pronovost-Morgan, C. et al. An international Delphi consensus for reporting of setting in psychedelic clinical trials. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03685-9 (2025).","journal-title":"Nat. Med."},{"key":"39261_CR102","doi-asserted-by":"publisher","DOI":"10.1177\/00048674221139962","author":"RM McMillan","year":"2022","unstructured":"McMillan, R. M. & Fernandez, A. V. Understanding subjective experience in Psychedelic-Assisted psychotherapy: the need for phenomenology. Australian New. Z. J. Psychiatry. https:\/\/doi.org\/10.1177\/00048674221139962 (2022).","journal-title":"Australian New. Z. J. Psychiatry"},{"key":"39261_CR103","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41386-022-01424-z","volume":"48","author":"KM Nautiyal","year":"2023","unstructured":"Nautiyal, K. M. & Yaden, D. B. Does the trip matter? Investigating the role of the subjective effects of psychedelics in persisting therapeutic effects. Neuropsychopharmacol 48, 215\u2013216 (2023).","journal-title":"Neuropsychopharmacol"},{"key":"39261_CR104","doi-asserted-by":"publisher","DOI":"10.1162\/IMAG.a.907","author":"K Egger","year":"2025","unstructured":"Egger, K. et al. Meditation, Psychedelics, and brain connectivity: a randomised controlled Resting-State fMRI study of N,N -Dimethyltryptamine and Harmine in a meditation retreat. Imaging Neurosci. https:\/\/doi.org\/10.1162\/IMAG.a.907 (2025).","journal-title":"Imaging Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39261-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:25:09Z","timestamp":1781641509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39261-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39261"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39261-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article: JTTS, DM, RG, EV and DA report having no conflicts of interest with respect to research, authorship, and\/or publication of this article. MS declares that he co-founded Reconnect Labs, an academic spin-off at the University of Zurich, focused on the development of psychedelic medicines for mental health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14236"}}